Vibe at ViVE: What Developments Hold Healthcare Executives’ Attention in 2024?

06 Mar 2024
MedCity News Senior Reporter Katie Adams with Gary Lynch, global practice lead and CTO for Insurance and Life Science with Verizon Business. At the ViVE event in Los Angeles, February 25-28, health tech executives shared how their companies are putting innovative ideas into action to address the most pressing needs in healthcare. Verizon Business Gary Lynch, global practice leader, and CTO — Insurance and Life Science at Verizon Business, shared how it is improving healthcare access for high-risk patient populations. He also talked about the Verizon Business collaboration with UC Davis to improve health equity. EY Aloha McBride, EY global health leader, shared her perspective on AI adoption in healthcare with MedCity News editor-in-chief Arundhati Parmar. McBride called on company leaders to commit to AI at scale, but first they need to have a vision for what AI looks like for businesses. Quantum Health Zane Burke, Quantum Health CEO, highlighted the value healthcare navigation companies can offer self-insured employers. TruBridge Chris Fowler, TruBridge CEO, talked about how the business is focused on relieving paint points in rural healthcare through a comprehensive offering of services and technology supporting medical coding and billing. Corti Andreas Cleve, Corti CEO, talked with MedCity News reporter Katie Adams about its AI co-pilot for clinicians, highlighting its tool’s capabilities. Artera Sarah Shillington, Chief Customer Officer with Artera, talked about how it is using the Harmony omnichannel platform to improve and organize care management to serve its 750+ provider customers. Clarify Health Neechi Mosha MD, SVP of Growth with Clarify Health, highlighted how it is leveraging technology for two sides of its business — provider growth and provider performance. Mosha also discussed how the company has amassed so much healthcare data and how it thinks about partnerships. First Dollar Jason Bornhorst, CEO and co-founder, explained First Dollar’s business and how it works with customers on HSAs.
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.